Rapid Diagnostic Kits Market for Indian Ocean Region Countries (2022-2029)
The Rapid Diagnostic Kits Market for Indian Ocean Region Countries is expected to register a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029.
- Published
- Jan 2023
- Pages
- 145
- Format
- PDF + Excel
- Report ID
- MRHC - 104734
- Base year
- 2021
- 2029 · FORECAST
- $1.75B
- 2029
- $1.75B
- CAGR 2022–2029
- 1.6%
2021 baseline · 2022–2029 forecast at 1.6% CAGR · hover a bar for the value
Key highlights
The professional kits segment is expected to account for the larger share of the rapid diagnostic kits market in Indian Ocean region countries in 2022. The large market share of this segment is attributed to the availability of disease-specific assays for the early diagnosis of chronic diseases, technological advancements in rapid diagnostics, and the high awareness of professional rapid diagnostic kits.
The immunoassays segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries in 2022. The large market share of this segment is mainly attributed to the high prevalence of chronic and infectious diseases, technological innovations, and the advantages of rapid immunoassay tests, such as cost-effectiveness and at-home testing.
India is expected to be the fastest-growing country during the forecast period. Factors driving the growth of this country include the rising prevalence of chronic diseases and initiatives taken by the government to promote health awareness in the country. According to National AIDS Control Organisation (NACO), around 6% of the adult population (around 30 million people) in India is diagnosed with reproductive tract infections (RTIs) each year, including sexually transmitted infections (STIs). As rapid diagnostics can facilitate accurate and quick diagnosis and management of diseases, the demand for rapid diagnostic kits in India is expected to grow exponentially in the coming years.
In recent years, government initiatives have increased to promote health awareness in the country. Pradhan Mantri Jan Arogya Yojana, Ayushman Bharat, and Mission Indradhanush are some of the recent initiatives launched by the Government of India to promote health awareness. These initiatives are expected to boost the demand for rapid diagnostic kits leading to the growth of this market.
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2021 |
| Estimated Year | 2022 |
| Forecast Period | 2022–2029 |
| Market Size (2029) | USD 1.75 billion |
| CAGR (2022–2029) | 1.6% |
| Format | PDF, Excel & Cloud Portal · 145 pages |
| Segments Covered | By Product: Professional Kits, OTC Kits · By Platform: Immunoassays, Molecular Detection, Other Rapid Diagnostic Platforms · By Application: Infectious Diseases Testing, Pregnancy And Fertility Testing, Cardiac Metabolism Testing, Cholesterol Testing, Tumor/Cancer Markers Testing, Blood Glucose Testing, Urinalysis, Hematology Testing, Other Tests · By End User: Hospitals & Clinics, Diagnostic Laboratories, Home Care/Self-testing, Other End Users |
| Countries Covered | Europe (France), Asia-Pacific (India, Australia, Indonesia, Singapore, Sri Lanka, Madagascar, Mauritius, Reunion, Mayotte, Seychelles, Comoros) |
| Key Companies | Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc., Meridian Bioscience, Inc. (U.S.), Trinity Biotech plc |
Report overview
Segments covered: product, platform, application, end user. Regions: Europe, Asia-Pacific.
The rapid diagnostics kits market for Indian Ocean region countries covers professional kits and OTC kits offered by key companies in the market to hospitals, clinical laboratories, and home care settings for the qualitative and quantitative detection of specific antigens, antibodies, genetic material, or proteins associated with a particular health condition or disease, helping uncover the underlying mechanisms of diseases and enabling doctors and healthcare workers to make crucial medical decisions. These test kits provide diagnostic results expeditiously (within 1 hour). For the scope of this report, the Indian Ocean region countries include France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles.
The growth of this market is driven by the growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic. Moreover, emerging markets are expected to offer growth opportunities for the players operating in the rapid diagnostic kits market in Indian Ocean region countries. However, variance in test results is a restraining factor for the growth of this market. Additionally, the reluctance to change the existing diagnostic practices is a major challenge for market growth.
Report infographic
Market dynamics
1 factors across 1 forceGrowing Prevalence of Infectious Diseases: Driving the Growth of the Market
Diagnostic tests play a crucial role in the medical care of patients with infections. Usual methods for detecting specific pathogens are generally time-consuming and expensive and require complex analytical instruments and skilled technicians. Also, rapid diagnostic tests are in demand as they can diagnose infectious diseases early, which helps prevent their spread. Rapid diagnostic kits for diagnosing infectious diseases are in high demand in the in-vitro diagnostics (IVD) industry due to the increasing awareness regarding infectious diseases in developing countries, expanding test menus, and advancements in molecular testing and lab-on-chip technology. As the demand for rapid diagnostic kits increases, manufacturing companies compete to develop next-generation rapid diagnostics platforms that are faster, easier to use, and more reliable.
In recent years, the incidence of infectious diseases has increased considerably. For instance, In India, every year, 30 million new cases of sexually transmitted diseases (STDs) and reproductive tract infections (RTIs) are reported. Also, the prevalence of HIV in the population aged 15–49 years is 0.2%. Although the prevalence rate is extremely low, it translates to 2.1 million people due to India’s high population. In addition to this, Indonesia has a high prevalence of tuberculosis. According to the WHO, in 2020, Indonesia accounted for 8.4% of all estimated tuberculosis cases globally. Hence, the growing incidence of infectious diseases further boosted the demand for rapid diagnostic kits to diagnose and manage various infectious diseases. Therefore, looking at the overall scenario, the growing prevalence of infectious diseases is estimated to drive the growth of the rapid diagnostic kits market in Indian Ocean region countries.
Table of contents
12 chapters · 79 sections · 145 pages · click to expandSegmental analysis
| Segment | Largest share (2022) | Fastest growth (2022–2029) |
|---|---|---|
| By Application | Infectious diseases testing | — |
| Other segments | Hospital & Clinics | — |
By Application
- Infectious Diseases Segment to Register Largest Share in the Rapid Diagnostics Kits Market for Indian Ocean Region Countries in 2022
- The infectious diseases testing segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries in 2022.
- The high prevalence of target diseases and outbreaks of infectious diseases and the rise in the awareness and adoption of self-testing kits for infectious diseases are supporting the large market share of this segment.
Other segments
- Hospital & Clinics Segment to Dominate the Market in 2022
- The hospital & clinics segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries in 2022.
- The high rate of hospitalizations due to various diseases, the rising geriatric population, and increased healthcare access & expenditure are the primary factors contributing to the largest share of the market.
Competitive landscape
- Becton
- Dickinson and Company (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd · Switzerland
- ACON Laboratories, Inc. (U.S.)
- Danaher Corporation (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Alfa Scientific Designs, Inc. (U.S.)
- BTNX Inc. · Canada
- Meridian Bioscience, Inc. (U.S.)
- Trinity Biotech plc · Ireland
Frequently asked questions
This report provides an analysis of the rapid diagnostic kits market in Indian Ocean region countries (France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles), covering platforms such as immunoassays and molecular detection used for applications such as blood glucose testing, cardiac metabolism testing, infectious diseases testing, coagulation testing, pregnancy & fertility testing, fecal occult testing, hematology testing, tumor/cancer markers testing, drugs of abuse testing, cholesterol testing, and urinalysis. The rapid diagnostics kits covered in this report provide diagnostic results expeditiously (within 1 hour).
Cite this report
Meticulous Research. (2023). Rapid Diagnostic Kits Market for Indian Ocean Region Countries - Opportunity Analysis and Industry Forecast (2022-2029) (Report No. MRHC - 104734). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/rapid-diagnostics-kits-market-for-indian-ocean-region-countries-5418